Oxford Global is proud to present the 3rd Oncology Biomarkers Congress to be held on the 14th -15th October 2013, Manchester. It is to be co-located with our Oncology Clinical Development Congress.
Over the 2 days, the event provides a first class educational and networking opportunity for over 150 attendees to gain knowledge and insights into the Oncology biomarkers market. The event will bring together key scientists whose expertise is focused on biomarkers, companion diagnostics, personalized medicine, safety studies, translational medicine and decision making in the oncology therapeutic area, from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.
Over the 2 days, the event provides a first class educational and networking opportunity for over 150 attendees to gain knowledge and insights into the Oncology biomarkers market. The event will bring together key scientists whose expertise is focused on biomarkers, companion diagnostics, personalized medicine, safety studies, translational medicine and decision making in the oncology therapeutic area, from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.
